⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
SkinnyRx GLP-1 Weight Loss 2026: Compounded Semaglutide and Tirzepatide Program, Pricing, and FDA Regulatory Status Examined
globenewswire.com
ELAN
LLY
NVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
prnewswire.com
NVO
PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race
globenewswire.com
MDBH
LLY
NVO
PFE
AZN
GILD
GPCR
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Novo Nordisk A/S (NVO) And Encourages Investors to Reach Out
accessnewswire.com
NVO
Walgreens Virtual Healthcare Adds Weight Management Services to Support Patients on Their Weight Loss Journey
businesswire.com
NVO
Commitments Received for ~A$8.2m Placement
globenewswire.com
NVO
New Study Shows Scripps Patients Maintained Weight Loss After Reducing GLP-1 Treatment Frequency
globenewswire.com
LLY
NVO
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Novo Nordisk A/S (NVO) And Encourages Stockholders to Reach Out
accessnewswire.com
NVO
NVO Investors Have Opportunity to Join Novo Nordisk A/S Fraud Investigation with the Schall Law Firm
globenewswire.com
NVO
Prefilled Syringes Market Analysis Report 2026-2031: Rising Self-Injection of GLP-1 Obesity Drugs, Shift to Biologic-Friendly COP Syringes, Glass Delamination Recalls in High-pH Biologics
globenewswire.com
NVO